Puromycin analogs. Ribosomal binding and peptidyl transferase substrate activity of a carbocyclic analog of 8-azapuromycin

Peter H. Duquette, Clare L. Ritter, Robert Vince

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The synthesis of an 8-aza carbocyclic puromycin analog, 7-dimethylamino-3-{(R)-[(2R)-hydroxy-(3R)-(p-methoxyphenyl-l-alanylamino)]cyclopentyl}-v-triazolo[4, 5-d]pyrimidine (1), is described. The previously described carbocyclic pyrimidine, 2α-acetamido-5β-(5-amino-6-chloro-4-pyrimidinylamino)cyclopentan-1α-ol (2), was diazotized and converted to the corresponding 8-azapurine (4). Treatment of 4 with aqueous dimethylamine followed by acid hydrolysis of the acetamido blocking group gave the amino nucleoside analog (6). Coupling of 6 with N-benzyloxycarbonyl-p-methoxyphenyl-l-alanine, followed by hydrogenolysis of the Cbz blocking group, gave a mixture of 1 and its diastereoisomer, 7-dimethylamino-3-{(S)-[(2S)-hydroxy-(3S)-(p-methoxyphenyl-l-alanylamino)] cyclopentyl}-v-triazolo[4, 5-d]pyrimidine (2). The diastereomers were separated by chromatography. Biological testing with Escherichia coli ribosomes provides a comparison of the relative ribosomal binding affinities and peptidyl transferase substrate activities of puromycin and 8-aza carbocyclic puromycin. Kinetic data indicate that such compounds are capable of binding to the ribosomal acceptor site and act as peptidyl transferase substrates in a manner identical with the mechanism of action of puromycin.

Original languageEnglish (US)
Pages (from-to)4855-4859
Number of pages5
JournalBiochemistry
Volume13
Issue number23
DOIs
StatePublished - Nov 1 1974

Fingerprint

Peptidyl Transferases
Puromycin
Substrates
Hydrogenolysis
Chromatography
Ribosomes
Nucleosides
Alanine
Escherichia coli
Hydrolysis
Kinetics
Acids
Testing
pyrimidine
carbocyclic puromycin

Cite this

Puromycin analogs. Ribosomal binding and peptidyl transferase substrate activity of a carbocyclic analog of 8-azapuromycin. / Duquette, Peter H.; Ritter, Clare L.; Vince, Robert.

In: Biochemistry, Vol. 13, No. 23, 01.11.1974, p. 4855-4859.

Research output: Contribution to journalArticle

@article{447d54c346f647448faf9197b505e539,
title = "Puromycin analogs. Ribosomal binding and peptidyl transferase substrate activity of a carbocyclic analog of 8-azapuromycin",
abstract = "The synthesis of an 8-aza carbocyclic puromycin analog, 7-dimethylamino-3-{(R)-[(2R)-hydroxy-(3R)-(p-methoxyphenyl-l-alanylamino)]cyclopentyl}-v-triazolo[4, 5-d]pyrimidine (1), is described. The previously described carbocyclic pyrimidine, 2α-acetamido-5β-(5-amino-6-chloro-4-pyrimidinylamino)cyclopentan-1α-ol (2), was diazotized and converted to the corresponding 8-azapurine (4). Treatment of 4 with aqueous dimethylamine followed by acid hydrolysis of the acetamido blocking group gave the amino nucleoside analog (6). Coupling of 6 with N-benzyloxycarbonyl-p-methoxyphenyl-l-alanine, followed by hydrogenolysis of the Cbz blocking group, gave a mixture of 1 and its diastereoisomer, 7-dimethylamino-3-{(S)-[(2S)-hydroxy-(3S)-(p-methoxyphenyl-l-alanylamino)] cyclopentyl}-v-triazolo[4, 5-d]pyrimidine (2). The diastereomers were separated by chromatography. Biological testing with Escherichia coli ribosomes provides a comparison of the relative ribosomal binding affinities and peptidyl transferase substrate activities of puromycin and 8-aza carbocyclic puromycin. Kinetic data indicate that such compounds are capable of binding to the ribosomal acceptor site and act as peptidyl transferase substrates in a manner identical with the mechanism of action of puromycin.",
author = "Duquette, {Peter H.} and Ritter, {Clare L.} and Robert Vince",
year = "1974",
month = "11",
day = "1",
doi = "10.1021/bi00720a026",
language = "English (US)",
volume = "13",
pages = "4855--4859",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "23",

}

TY - JOUR

T1 - Puromycin analogs. Ribosomal binding and peptidyl transferase substrate activity of a carbocyclic analog of 8-azapuromycin

AU - Duquette, Peter H.

AU - Ritter, Clare L.

AU - Vince, Robert

PY - 1974/11/1

Y1 - 1974/11/1

N2 - The synthesis of an 8-aza carbocyclic puromycin analog, 7-dimethylamino-3-{(R)-[(2R)-hydroxy-(3R)-(p-methoxyphenyl-l-alanylamino)]cyclopentyl}-v-triazolo[4, 5-d]pyrimidine (1), is described. The previously described carbocyclic pyrimidine, 2α-acetamido-5β-(5-amino-6-chloro-4-pyrimidinylamino)cyclopentan-1α-ol (2), was diazotized and converted to the corresponding 8-azapurine (4). Treatment of 4 with aqueous dimethylamine followed by acid hydrolysis of the acetamido blocking group gave the amino nucleoside analog (6). Coupling of 6 with N-benzyloxycarbonyl-p-methoxyphenyl-l-alanine, followed by hydrogenolysis of the Cbz blocking group, gave a mixture of 1 and its diastereoisomer, 7-dimethylamino-3-{(S)-[(2S)-hydroxy-(3S)-(p-methoxyphenyl-l-alanylamino)] cyclopentyl}-v-triazolo[4, 5-d]pyrimidine (2). The diastereomers were separated by chromatography. Biological testing with Escherichia coli ribosomes provides a comparison of the relative ribosomal binding affinities and peptidyl transferase substrate activities of puromycin and 8-aza carbocyclic puromycin. Kinetic data indicate that such compounds are capable of binding to the ribosomal acceptor site and act as peptidyl transferase substrates in a manner identical with the mechanism of action of puromycin.

AB - The synthesis of an 8-aza carbocyclic puromycin analog, 7-dimethylamino-3-{(R)-[(2R)-hydroxy-(3R)-(p-methoxyphenyl-l-alanylamino)]cyclopentyl}-v-triazolo[4, 5-d]pyrimidine (1), is described. The previously described carbocyclic pyrimidine, 2α-acetamido-5β-(5-amino-6-chloro-4-pyrimidinylamino)cyclopentan-1α-ol (2), was diazotized and converted to the corresponding 8-azapurine (4). Treatment of 4 with aqueous dimethylamine followed by acid hydrolysis of the acetamido blocking group gave the amino nucleoside analog (6). Coupling of 6 with N-benzyloxycarbonyl-p-methoxyphenyl-l-alanine, followed by hydrogenolysis of the Cbz blocking group, gave a mixture of 1 and its diastereoisomer, 7-dimethylamino-3-{(S)-[(2S)-hydroxy-(3S)-(p-methoxyphenyl-l-alanylamino)] cyclopentyl}-v-triazolo[4, 5-d]pyrimidine (2). The diastereomers were separated by chromatography. Biological testing with Escherichia coli ribosomes provides a comparison of the relative ribosomal binding affinities and peptidyl transferase substrate activities of puromycin and 8-aza carbocyclic puromycin. Kinetic data indicate that such compounds are capable of binding to the ribosomal acceptor site and act as peptidyl transferase substrates in a manner identical with the mechanism of action of puromycin.

UR - http://www.scopus.com/inward/record.url?scp=0016170994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016170994&partnerID=8YFLogxK

U2 - 10.1021/bi00720a026

DO - 10.1021/bi00720a026

M3 - Article

VL - 13

SP - 4855

EP - 4859

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 23

ER -